Impel NeuroPharma, Inc. announced the appointment of Adrian Adams as Chairman of the Board, effective January 8, 2020. Adrian is a highly experienced life sciences executive who has served as the Chief Executive Officer of multiple companies over the past seventeen years and also brings a wealth of board governance expertise, having served as a non-executive director and Chairman for several public and private businesses. Prior to this appointment, Adrian held the position of Chief Executive Officer of Aralez Pharmaceuticals Inc. and served in this role with the company's predecessor, POZEN Inc.